Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

This publication has 15 references indexed in Scilit:

• Live attenuated tetravalent dengue vaccine
  Vaccine, 2000
• Dengue and dengue haemorrhagic fever
  The Lancet, 1998
• Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
  Vaccine, 1996
• A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For Humans
  The Journal of Infectious Diseases, 1994
• Dengue: the risk to developed and developing countries.
  Proceedings of the National Academy of Sciences, 1994
• In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virus
  Journal of General Virology, 1991
• STUDY OF BIVALENT DENGUE VACCINE IN VOLUNTEERS
  The Lancet, 1989
• Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.
  Journal of Clinical Investigation, 1989
• RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZIL
  The Lancet, 1988
• Dengue 2 Vaccine: Dose Response in Volunteers in Relation to Yellow Fever Immune Status
  The Journal of Infectious Diseases, 1983